Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada

Data Availability

Sharing of de-identified data that underpin the vaccine effectiveness results reported in this article will be considered upon request with appropriate review and aggregation as required to comply with respective provincial/national privacy and confidentiality legislation and through secure file transfer protocols. Information regarding submitting proposals and accessing data may be obtained through the corresponding authors.